Display options
Cite
Sezer A, Hatipoglu AR, Usta U, et al. Effects of intraperitoneal melatonin on caustic sclerosing cholangitis due to scolicidal solution in a rat model. Curr Ther Res Clin Exp. 2010;71(2):118-28doi: 10.1016/j.curtheres.2010.03.004.
Sezer, A., Hatipoglu, A. R., Usta, U., Altun, G., & Sut, N. (2010). Effects of intraperitoneal melatonin on caustic sclerosing cholangitis due to scolicidal solution in a rat model. Current therapeutic research, clinical and experimental, 71(2), 118-28. https://doi.org/10.1016/j.curtheres.2010.03.004
Sezer, Atakan, et al. "Effects of intraperitoneal melatonin on caustic sclerosing cholangitis due to scolicidal solution in a rat model." Current therapeutic research, clinical and experimental vol. 71,2 (2010): 118-28. doi: https://doi.org/10.1016/j.curtheres.2010.03.004
Sezer A, Hatipoglu AR, Usta U, Altun G, Sut N. Effects of intraperitoneal melatonin on caustic sclerosing cholangitis due to scolicidal solution in a rat model. Curr Ther Res Clin Exp. 2010 Apr;71(2):118-28. doi: 10.1016/j.curtheres.2010.03.004. PMID: 24683258; PMCID: PMC3967282.
Copy Download .nbib Format: NLM
Share it on

Curr Ther Res Clin Exp. 2010 Apr;71(2):118-28. doi: 10.1016/j.curtheres.2010.03.004.

Effects of intraperitoneal melatonin on caustic sclerosing cholangitis due to scolicidal solution in a rat model.

Current therapeutic research, clinical and experimental

Atakan Sezer, Ahmet Rahmi Hatipoglu, Ufuk Usta, Gülay Altun, Necdet Sut

Affiliations

  1. Department of General Surgery, Faculty of Medicine, Trakya University, Edirne, Turkey.
  2. Department of Pathology, Faculty of Medicine, Trakya University, Edirne, Turkey.
  3. Department of Nuclear Medicine, Faculty of Medicine, Trakya University, Edirne, Turkey.
  4. Department of Biostatistics, Faculty of Medicine, Trakya University, Edirne, Turkey.

PMID: 24683258 PMCID: PMC3967282 DOI: 10.1016/j.curtheres.2010.03.004

Abstract

BACKGROUND: Hydatid disease is a worldwide health problem. Treatment is surgical or percutaneous, using scolicidal agents. Caustic sclerosing cholangitis might develop after the contact of scolicidal agents with the biliary ducts. Melatonin, an antioxidant, anti-inflammatory, and anticarcinogenic agent, might be used in the treatment of caustic sclerosing cholangitis due to its possible preventive effects on fibrosis and cell damage.

OBJECTIVE: The aim of the study was to investigate the effects of melatonin on an experimentally developed caustic sclerosing cholangitis with scolicidal solution (formalin) in a rat model.

METHODS: Forty female Sprague-Dawley rats aged 11 to 13 weeks and weighing 250 ± 30 g were randomly assigned to 1 of 4 groups of 10: formalin 5% at 0.5 mL/d + melatonin placebo; formalin placebo + intraperitoneal melatonin 10 mg/kg/d; formalin 5% at 0.5 mL/d + melatonin 10 mg/kg/d; and formalin placebo and melatonin placebo (control). Hepatobiliary function was assessed using dynamic scintigraphy with technetium-99m-mebrofenin on study day 60. The histology of the liver and biliary duct specimens was examined on study day 60. In each group, histopathologic alterations were scored as absent, slight, mild, or severe.

RESULTS: Mean severity scores for parenchymal necrosis in the liver (P < 0.01), portal fibrosis (P < 0.01), biliary duct proliferation (P < 0.001), cholangitis/ pericholangitis (P < 0.01), hyperemia in the biliary ducts (P < 0.01), and fibrosis (P < 0.01) were significantly lower in rats treated with formalin + melatonin compared with those treated with formalin alone. No significant differences were observed between the 3 treatment groups with respect to t½, a parameter used to assess the secretion function of the hepatocytes. However, the t½ was significantly longer in the treatment groups compared with controls (P < 0.001).

CONCLUSION: In this experimental study in a rat model of caustic sclerosing cholangitis, the histopathologic and scintigraphic findings suggested that melatonin is effective in attenuating the damage caused by scolicidal agents on the liver and biliary ducts.

Keywords: caustic sclerosing cholangitis; hydatid cyst; melatonin; scolicidal solutions

References

  1. Vet Res Commun. 2009 Sep;33 Suppl 1:47-52 - PubMed
  2. Arch Surg. 1986 Oct;121(10):1162-5 - PubMed
  3. Neurosci Biobehav Rev. 1993 Fall;17(3):347-57 - PubMed
  4. Mayo Clin Proc. 1991 Dec;66(12):1193-7 - PubMed
  5. World J Gastroenterol. 2005 Apr 7;11(13):1951-6 - PubMed
  6. J Invest Surg. 2004 Nov-Dec;17(6):323-6 - PubMed
  7. J Pineal Res. 2005 Sep;39(2):143-50 - PubMed
  8. Acta Histochem. 2004;106(5):331-6 - PubMed
  9. Khirurgiia (Sofiia). 1998;51(1):47-50 - PubMed
  10. Free Radic Res. 2004 Jul;38(7):697-704 - PubMed
  11. Am J Surg. 1984 Nov;148(5):694-7 - PubMed
  12. Eur J Surg. 1995 Apr;161(4):299-300 - PubMed
  13. Arch Surg. 1990 Aug;125(8):1059-61 - PubMed
  14. Minerva Med. 1989 Aug;80(8):865-8 - PubMed
  15. Khirurgiia (Sofiia). 1998;51(3):40-1 - PubMed
  16. J Pineal Res. 2001 Sep;31(2):138-44 - PubMed
  17. J Hepatol. 2004 Jan;40(1):86-93 - PubMed
  18. Chirurgia (Bucur). 1992;41(1):32-42 - PubMed
  19. J Pineal Res. 2004 Jan;36(1):43-8 - PubMed
  20. Br J Surg. 2003 Dec;90(12):1536-41 - PubMed
  21. Yonsei Med J. 2007 Aug 31;48(4):659-64 - PubMed
  22. Biol Signals Recept. 2000 May-Aug;9(3-4):137-59 - PubMed
  23. Clin Exp Rheumatol. 1996 Sep-Oct;14(5):493-8 - PubMed
  24. Hepatogastroenterology. 1994 Oct;41(5):458-70 - PubMed
  25. World J Gastroenterol. 2005 Jan 7;11(1):7-16 - PubMed
  26. Life Sci. 2001 Jun 22;69(5):543-51 - PubMed

Publication Types